Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.48 is 95% above its 4-year average of -30.60, near the high end of its 4-year range (-67.80–-1.48).
57.71% above its 12-month average of -3.50.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.35.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 19 comparable quarters.
EARNINGS PER SHARE (EPS)
-1.48
EARNINGS PER SHARE (EPS) AVG TTM
-3.50
EARNINGS PER SHARE (EPS) AVG 3Y
-21.30
EARNINGS PER SHARE (EPS) AVG 5Y
-30.60
EARNINGS PER SHARE (EPS) AVG 10Y
-28.49
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+57.71%
CURRENT VS 3Y AVG
+93.05%
CURRENT VS 5Y AVG
+95.16%
CURRENT VS 10Y AVG
+94.81%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
PolyPid Ltd.
Market Cap
$99.04M
Earnings Per Share (EPS)
-1.48
TTM Avg
-3.50
3Y Avg
-21.30
5Y Avg
-30.60
Market Cap
$97.30M
Earnings Per Share (EPS)
-0.69
TTM Avg
-0.71
3Y Avg
-1.04
5Y Avg
-1.15
Market Cap
$97.40M
Earnings Per Share (EPS)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$96.95M
Earnings Per Share (EPS)
-10.01
TTM Avg
-10.93
3Y Avg
-75.63
5Y Avg
-58.09
Market Cap
$102.24M
Earnings Per Share (EPS)
0.27
TTM Avg
-0.10
3Y Avg
-0.20
5Y Avg
0.10
Market Cap
$103.06M
Earnings Per Share (EPS)
-3.50
TTM Avg
-4.18
3Y Avg
-3.30
5Y Avg
-7.15
Market Cap
$104.79M
Earnings Per Share (EPS)
-0.30
TTM Avg
-0.36
3Y Avg
-0.38
5Y Avg
-0.40
Market Cap
$105.20M
Earnings Per Share (EPS)
-1.60
TTM Avg
-2.42
3Y Avg
-1.68
5Y Avg
-1.45
Market Cap
$93.01M
Earnings Per Share (EPS)
-0.91
TTM Avg
0.49
3Y Avg
1.23
5Y Avg
1.23
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PolyPid Ltd. (PYPD) | $99.04M | -1.48 | -3.50 | -21.30 | -30.60 |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $97.30M | -0.69 | -0.71 | -1.04 | -1.15 |
| Conexeu Sciences Inc. (CNXU)vs › | $97.40M | N/A | N/A | N/A | N/A |
| Korro Bio, Inc. (KRRO)vs › | $96.95M | -10.01 | -10.93 | -75.63 | -58.09 |
| The Joint Corp. (JYNT)vs › | $102.24M | 0.27 | -0.10 | -0.20 | 0.10 |
| OnKure Therapeutics, Inc. (OKUR)vs › | $103.06M | -3.50 | -4.18 | -3.30 | -7.15 |
| Anixa Biosciences, Inc. (ANIX)vs › | $104.79M | -0.30 | -0.36 | -0.38 | -0.40 |
| Definitive Healthcare Corp. (DH)vs › | $105.20M | -1.60 | -2.42 | -1.68 | -1.45 |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $93.01M | -0.91 | 0.49 | 1.23 | 1.23 |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $105.67M | -0.12 | -0.17 | -0.12 | -0.12 |
Trailing EPS (TTM)
$-1.48
Forward EPS (Est.)
$-1.67
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -2.09 |
| 2024-12-31 | -4.91 |
| 2023-12-31 | -16.99 |
| 2022-12-31 | -61.20 |
| 2021-12-31 | -67.80 |
| 2019-12-31 | -15.03 |
| 2018-12-31 | 26.70 |
| 2016-12-31 | -77.48 |
| 2015-12-31 | -37.62 |
| 2013-12-31 | -39.58 |
| 2012-12-31 | -8.08 |
